Benchmark Downgrades Emergent BioSolutions (EBS) to Hold, 'Restructuring Plans to Slow Share Price Rebound'
Tweet Send to a Friend
(Updated - August 29, 2023 6:18 AM EDT)
Benchmark analyst Robert Wasserman downgraded Emergent BioSolutions (NYSE: EBS) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Benchmark analyst Robert Wasserman downgraded Emergent BioSolutions (NYSE: EBS) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
